Amarin Corp Adr (AMRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Amarin Corp Adr Stock (AMRN) Company Profile

Amarin Corp Adr

Healthcare (1118)

353 1 6699 020

SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AMRN's Discussions on Twitter

Compare AMRN vs LLY, JNJ, ABBV, AZN, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AMRN Amarin Corp Adr	15.83	340.56M	214.33M	-38.98M	6.74M	-1.8817
LLY Lilly Eli Co	988.16	872.68B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.66	583.29B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	224.07	398.49B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	189.93	298.53B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	153.96	294.33B	54.72B	14.02B	15.32B	7.1855

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-11-20	Fortgesetzt	JP Morgan	Underweight
2023-10-25	Herabstufung	Jefferies	Buy → Hold
2023-01-06	Hochstufung	Jefferies	Hold → Buy
2022-05-06	Herabstufung	JP Morgan	Neutral → Underweight
2022-05-05	Herabstufung	H.C. Wainwright	Buy → Neutral
2022-05-05	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2022-05-04	Herabstufung	Northland Capital	Outperform → Market Perform
2021-05-12	Herabstufung	Goldman	Neutral → Sell
2020-09-29	Fortgesetzt	JP Morgan	Neutral
2020-08-26	Eingeleitet	Piper Sandler	Overweight
2020-05-05	Eingeleitet	Northland Capital	Outperform
2020-03-31	Herabstufung	Goldman	Buy → Neutral
2020-03-31	Herabstufung	Jefferies	Buy → Hold
2020-03-31	Hochstufung	Oppenheimer	Underperform → Perform
2020-03-13	Hochstufung	Goldman	Neutral → Buy
2020-03-02	Eingeleitet	Cowen	Outperform
2020-02-18	Hochstufung	Citigroup	Neutral → Buy
2020-01-06	Eingeleitet	JP Morgan	Neutral
2019-12-16	Herabstufung	Stifel	Buy → Hold
2019-11-20	Eingeleitet	Oppenheimer	Underperform
2019-11-18	Herabstufung	Citigroup	Buy → Neutral
2019-11-15	Bestätigt	SVB Leerink	Outperform
2019-10-31	Eingeleitet	Aegis Capital	Buy
2019-10-15	Eingeleitet	Goldman	Neutral
2019-08-14	Eingeleitet	SVB Leerink	Outperform
2019-07-09	Bestätigt	Jefferies	Buy
2019-06-17	Eingeleitet	ROTH Capital	Buy
2019-03-22	Eingeleitet	Stifel	Buy

Alle ansehen

Amarin Corp Adr Aktie (AMRN) Neueste Nachrichten

Finanzdaten der Amarin Corp Adr-Aktie (AMRN)

Amarin Corp Adr (AMRN)

Amarin Corp Adr Stock (AMRN) Company Profile

Compare AMRN vs LLY, JNJ, ABBV, AZN, NVS

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Amarin Corp Adr Aktie (AMRN) Neueste Nachrichten

Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks - The Motley Fool

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz

Amarin Corporation Plc Sponsored ADR Trade Ideas — SWB:EH3 - TradingView

Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss - Finviz

Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 - ChartMill

Amarin (AMRN) Trailing Losses Narrow To US$38.8 Million Challenging Bearish Narratives - Sahm

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights - Finviz

AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - Finviz

China Universal Asset Management Co. Ltd. Sells 76,302 Shares of Amarin Corporation PLC $AMRN - Defense World

Net current asset value per share of Amarin Corporation Plc Sponsored ADR – MUN:EH3 - TradingView — Track All Markets

Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm

Tops & Flops Stocks - sharewise.com

Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - Sahm

Leerink Partners raises Amarin stock price target to $12 on strong Q3 - Investing.com

FDA updates fenofibrate labels to reflect lack of cardiovascular benefit - Investing.com

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - ADVFN

Cash from operating activities of Amarin Corporation Plc Sponsored ADR – SWB:EH3 - TradingView

Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - Sahm

Amarin Corporation plc Announces $17.8 Million Registered Direct Offering of American Depositary Shares - ADVFN

Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com

Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Yahoo Finance

Amarin Gears Up to Report Q2 Earnings: Here's What to Expect - Finviz

3 Strong Buy Breakout Stocks for Explosive Returns - The Globe and Mail

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz

PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - Finviz

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Nasdaq

Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Finviz

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail

SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease - Finviz

Kymera Stock Gains on Positive Data on Investigational Dermatitis Drug - Finviz

Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines - Finviz

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance

VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval - Finviz

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies - Finviz

Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown

Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com

Amarin urged to review strategy by major shareholders - Investing.com

The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26% - Sahm

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - Stock Titan

Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative

China approves VASCEPA to reduce cardiovascular risk - Investing.com

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Investing.com UK

Free float of Amarin Corporation Plc Sponsored ADR – NASDAQ:AMRN - TradingView

symbol__ Stock Quote Price and Forecast - CNN

Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.

Finanzdaten der Amarin Corp Adr-Aktie (AMRN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AMRN